Author(s): Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT, Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT
Abstract Share this page
Abstract In the past decade, chikungunya--a virus transmitted by Aedes spp mosquitoes--has re-emerged in Africa, southern and southeastern Asia, and the Indian Ocean Islands as the cause of large outbreaks of human disease. The disease is characterised by fever, headache, myalgia, rash, and both acute and persistent arthralgia. The disease can cause severe morbidity and, since 2005, fatality. The virus is endemic to tropical regions, but the spread of Aedes albopictus into Europe and the Americas coupled with high viraemia in infected travellers returning from endemic areas increases the risk that this virus could establish itself in new endemic regions. This Seminar focuses on the re-emergence of this disease, the clinical manifestations, pathogenesis of virus-induced arthralgia, diagnostic techniques, and various treatment modalities. Copyright Â© 2012 Elsevier Ltd. All rights reserved.
This article was published in Lancet
and referenced in Journal of Neuroinfectious Diseases